LYNDRA

pharmaceuticals for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, Read More

Classification Information

Class [5]
Pharmaceutical Products

Pharmaceuticals for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; antibiotics; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; pharmaceuticals for immunosuppression, namely, solid organ transplant.

Class [42]
Computer & Software Services & Scientific Services

Research and development services in the field of a platform for extended release pharmaceuticals.

Mark Details

Serial Number

UK00917452566

Mark Type

Word

Kind of mark

Individual